NATERA, INC. Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
NATERA, INC. (NTRA) reported Right-of-Use Asset Obtained in Exchange for Operating Lease Liability of $28.19 million for the 3-month period ending 2019-09-30, per its 10-Q filed 2020-11-06.
Discontinued › Notes › Leases
us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability · last filed 2020-11-06
- NATERA, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2019-09-30 was $28.19M.
- NATERA, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2019-06-30 was $28.19M.
- NATERA, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2019-03-31 was $28.19M.
| Period end | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 3 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 6 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 9 month |
|---|---|---|---|
| 2019-09-30 | $28.19M 10-Q · filed 2020-11-06 | $56.38M derived: sum of 2 quarters · filed 2020-11-06 | $28.19M 10-Q · filed 2019-11-08 |
| 2019-06-30 | $28.19M 10-Q · filed 2020-08-07 | $28.19M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $28.19M 10-Q · filed 2020-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |